Literature DB >> 2178338

Erythromycin and azithromycin transport into Haemophilus influenzae ATCC 19418 under conditions of depressed proton motive force (delta mu H).

J O Capobianco1, R C Goldman.   

Abstract

The effect of collapsing the electrochemical proton gradient (delta mu H) on [3H]erythromycin and [14C]azithromycin transport in Haemophilus influenzae ATCC 19418 was studied. The proton gradient and membrane potential were determined from the distribution of [2-14C]dimethadione and rubidium-86, respectively. delta mu H was reduced from 124 to 3 mV in EDTA-valinomycin-treated cells at 22 degrees C with 150 mM KCl and 0.1 mM carbonyl cyanide m-chlorophenylhydrazone. During the collapse of delta mu H, macrolide uptake increased. Erythromycin efflux studies strongly suggested that this increase was not due to an energy-dependent efflux pump but was likely due to increased outer membrane permeability. These data indicated that macrolide entry was not a delta mu H-driven active transport process but rather a passive diffusion process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2178338      PMCID: PMC171926          DOI: 10.1128/AAC.34.9.1787

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  The measurement of transmembrane electrochemical proton gradients.

Authors:  H Rottenberg
Journal:  J Bioenerg       Date:  1975-05

2.  The proton electrochemical gradient in Escherichia coli cells.

Authors:  E Padan; D Zilberstein; H Rottenberg
Journal:  Eur J Biochem       Date:  1976-04-01

3.  Macrolide accumulation by Bacteroides fragilis ATCC 25285.

Authors:  Y Muto; K Bandoh; K Watanabe; N Katoh; K Ueno
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

4.  Proton-coupled beta-galactoside translocation in non-metabolizing Escherichia coli.

Authors:  I West; P Mitchell
Journal:  J Bioenerg       Date:  1972-08

5.  A transmembrane pH gradient in Streptococcus faecalis: origin, and dissipation by proton conductors and N,N'-dicyclohexylcarbodimide.

Authors:  F M Harold; E Pavlasová; J R Baarda
Journal:  Biochim Biophys Acta       Date:  1970

6.  Sensitivity and resistance to erythromycin in Bacillus subtilis 168: the ribosomal binding of erythromycin and chloramphenicol.

Authors:  S B Taubman; N R Jones; F E Young; J W Corcoran
Journal:  Biochim Biophys Acta       Date:  1966-08-17

7.  Antibiotic uptake by alveolar macrophages.

Authors:  J D Johnson; W L Hand; J B Francis; N King-Thompson; R W Corwin
Journal:  J Lab Clin Med       Date:  1980-03

8.  Erythromycin, carbomycin, and spiramycin inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes.

Authors:  J R Menninger; D P Otto
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

9.  Release of membrane components from viable Haemophilus parainfluenzae by ethylenediaminetetraacetic acid-tris(hydroxymethyl)-aminomethane.

Authors:  A N Tucker; D C White
Journal:  J Bacteriol       Date:  1970-05       Impact factor: 3.490

10.  Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria.

Authors:  L D Sabath; V Lorian; D Gerstein; P B Loder; M Finland
Journal:  Appl Microbiol       Date:  1968-09
View more
  8 in total

1.  Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin.

Authors:  K Tateda; Y Ishii; T Matsumoto; N Furuya; M Nagashima; T Matsunaga; A Ohno; S Miyazaki; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

Review 2.  Seventy-Five Years of Research on Protein Binding.

Authors:  Axel Dalhoff
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

3.  Studies of the novel ketolide ABT-773: transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae.

Authors:  J O Capobianco; Z Cao; V D Shortridge; Z Ma; R K Flamm; P Zhong
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

4.  Cellular accumulation, localization, and activity of a synthetic cyclopeptamine in fungi.

Authors:  J O Capobianco; D Zakula; D J Frost; R C Goldman; L Li; L L Klein; P A Lartey
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

5.  Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis.

Authors:  S Pereyre; P Gonzalez; B De Barbeyrac; A Darnige; H Renaudin; A Charron; S Raherison; C Bébéar; C M Bébéar
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 6.  Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.

Authors:  D H Peters; H A Friedel; D McTavish
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

7.  Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis.

Authors:  R C Goldman; J O Capobianco
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

8.  Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens.

Authors:  Nicholas Dillon; Michelle Holland; Hannah Tsunemoto; Bryan Hancock; Ingrid Cornax; Joe Pogliano; George Sakoulas; Victor Nizet
Journal:  EBioMedicine       Date:  2019-07-25       Impact factor: 8.143

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.